PsyKey Inc. is vertically integrated in the research & development, production, and commercialization of therapeutic and medicinal entheogenic, adaptogenic, nootropic ingredients and formulations for its premium functional product lines which are developed by its mycology and botany experts. PsyKey ... PsyKey Inc. is vertically integrated in the research & development, production, and commercialization of therapeutic and medicinal entheogenic, adaptogenic, nootropic ingredients and formulations for its premium functional product lines which are developed by its mycology and botany experts. PsyKey understands the importance of access to support services and healthcare professionals and is continuously engaged in the development of tools that will aid in removing barriers and providing inclusivity. PsyKey is also engaged in the scientific development of patentable technologies pertaining to the composition, bioavailability and targeted delivery of entheogen-based therapeutics. Recently the Company acquired Vetcomm. VetComm is a veteran's education, and benefits company focused on assisting the over 20 million United States veterans that qualify for underutilized annual benefits and owed compensation. As a result, billions of dollars in veteran benefits go unclaimed every month in the United States. Show more
PsyKey, Inc., Achieves Key Revenue Milestone With Purchase Order Of Its Functional Mushroom Products CARSON CITY, NV -- January 12, 2022 -- InvestorsHub...
PsyKey Inc. Appoints Mental Health Professional Ms. Tessa Lawlor, B.A, M.A. to its Strategic Advisory Board CARSON CITY, NV -- June 2, 2021 -- InvestorsHub NewsWire...
PsyKey Inc. Completes Definitive Agreement with MycoVita to establish a Strategic Partnership focused on Research, Development and Commercialization of Mycology based...
PsyKey Inc Announces Letter of Intent with MycoVita Canada to Form Strategic Partnership for Advanced Mycology Product Development Las Vegas, Nevada, April 14...
PsyKey Inc. Announces Former Royal Bank of Canada Managing Director to Head Advisory Board Las Vegas, NV -- March 29, 2021 -- InvestorsHub NewsWire...
CECORS, INC. SHAREHOLDER UPDATE Las Vegas, NV -- January 14, 2021 -- InvestorsHub NewsWire -- CECORS, INC. (OTC PINK: CEOS...
CeCors Inc. Preparing Final Stages of Launching CannMedLive App LAS VEGAS, NV -- June 10, 2019 -- InvestorsHub NewsWire -- CeCors, Inc. (OTC PINK: CEOS), a Company...
CeCors Inc. (OTCBB: CEOS) today announced its entry into the Carrier Ethernet Switch marketplace, with the world?s first 10 terabit backplane. Jim Fiedler, Chairman and CEO...
CeCors Inc. (OTCBB:CEOS) announced today that Mark Perkell has joined the organization as Vice President and General Counsel. In this capacity, Perkell will be responsible for...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.001 | 3.84615384615 | 0.026 | 0.0299 | 0.0216 | 1147069 | 0.02557906 | CS |
4 | 0.003 | 12.5 | 0.024 | 0.03255 | 0.0171 | 1448655 | 0.0271611 | CS |
12 | 0.0007 | 2.66159695817 | 0.0263 | 0.03255 | 0.015 | 702200 | 0.02502782 | CS |
26 | 0.01194 | 79.2828685259 | 0.01506 | 0.0445 | 0.0113 | 654493 | 0.02721492 | CS |
52 | 0.0161 | 147.706422018 | 0.0109 | 0.0547 | 0.010504 | 659195 | 0.0278021 | CS |
156 | -0.023 | -46 | 0.05 | 0.139 | 0.0077 | 737280 | 0.04058965 | CS |
260 | 0.0205 | 315.384615385 | 0.0065 | 0.485 | 0.0005 | 694713 | 0.04486794 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.